Haplotype-based case-control study of the human CYP4F2 gene and essential hypertension in Japanese subjects

Hypertension Research

Volumn 31, Issue 9, 2008, Pages 1719-1726

  Fu, Zhenyan ^a,b   Nakayama, Tomohiro ^a,b   Sato, Naoyuki ^a   Izumi, Yoichi ^a   Kasamaki, Yuji ^a   Shindo, Atsushi ^a   Ohta, Masakatsu ^a   Soma, Masayoshi ^a   Aoi, Noriko ^a   Sato, Mikano ^a   Matsumoto, Koichi ^a   Ozawa, Yukio ^a   Ma, Yitong ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Androgen; Case control study; CYP4F2; Haplotype; Single nucleotide polymorphism

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 4F2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 55449126874     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1719     Document Type: Article

References (29)

1. Suzuki H, Kanno Y, Efficacy of Candesartan on Outcome in Saitama Trial (E-COST) Group: Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Hypertens Res 2005; 28: 307-314.
2. Sugimoto K, Katsuya T, Ohkubo T, et al: Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens Res 2004; 27: 551-556.
3. Capdevila JH, Falck JR, Harris RC: Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 2000; 41: 163-181.
4. Bylund J, Bylund M, Oliw EH: cDNA cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun 2001; 280: 892-897.
5. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK: Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem 2000; 275: 4118-4126.
6. Roman RJ: P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82: 131-185.
7. Kalsotra A, Cui X, Anakk S, Hinojos CA, Doris PA, Strobel HW: Renal localization, expression, and developmental regulation of P450 4F cytochromes in three substrains of spontaneously hypertensive rats. Biochem Biophys Res Commun 2005; 338: 423-431.
8. Gainer JV, Bellamine A, Dawson EP, et al: Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 2005; 111: 63-69.
9. Stec DE, Roman RJ, Flasch A, Rieder MJ: Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics 2007; 30: 74-81.
10. Fu Z, Nakayama T, Sato N, et al: A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men. J Hypertens 2008; 26: 453-461.
11. Sato M, Nakayama T, Soma M, et al: Association between prostaglandin E2 receptor gene and essential hypertension. Prostaglandins Leukot Essent Fatty Acids 2007; 77: 15-20.
12. Morita A, Nakayama T, Doba N, Hinohara S, Soma M: Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 2006; 29: 323-331.
13. Aoi N, Soma M, Nakayama T, et al: Variable number of tandem repeat of the 5′-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004; 27: 711-716.
14. Dempster AP, Laird NM, Rubin DB: Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc Ser B 1977; 39: 1-22.
15. Kobayashi Y, Nakayama T, Sato N, Izumi Y, Kokubun S, Soma M: Haplotype-based case-control study revealing an association between the adrenomedullin gene and proteinuria in subjects with essential hypertension. Hypertens Res 2005; 28: 229-236.
16. King LM, Gainer JV, David GL, et al: Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension. Pharmacogenet Genomics 2005; 15: 7-13.
17. Yu BN, Luo CH, Wang D, et al: CYP2C9 allele variants in Chinese hypertension patients and healthy controls. Clin Chim Acta 2004; 348: 57-61.
18. Kivistö KT, Niemi M, Schaeffeler E, et al: CYP3A5 genotype is associated with diagnosis of hypertension in elderly patients: data from the DEBATE Study. Am J Pharmacogenomics 2005; 5: 191-195.
19. Iwai N, Katsuya T, Ishikawa K, et al: Human prostacyclin synthase gene and hypertension: the Suita Study. Circulation 1999; 100: 2231-2236.
20. Sookoian S, Gianotti TF, Gonzalez CD, Pirola CJ: Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens 2007; 25: 5-13.
21. McGiff JC, Quilley J: 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 2001; 10: 231-237.
22. Jin R, Koop DR, Raucy JL, Lasker JM: Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch Biochem Biophys 1998; 359: 89-98.
23. Morris RW, Kaplan NL: On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221-233.
24. O'Donnell CJ, Lindpaintner K, Larson MG, et al: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97: 1766-1772.
25. Ono K, Mannami T, Iwai N: Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women. J Hypertens 2003; 21: 1497-1503.
26. Waxman DJ, Ram PA, Pampori NA, Shapiro BH: Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol Pharmacol 1995; 48: 790-797.
27. Muller DN, Schmidt C, Barbosa-Sicard E, et al: Mouse Cyp4a isoforms: enzymatic properties, gender- and strainspecific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochem J 2007; 40: 109-118.
28. Holla VR, Adas F, Imig JD, et al: Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A 2001; 98: 5211-5216.
29. Nakagawa K, Holla VR, Wei Y, et al: Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J Clin Invest 2006; 116: 1696-1702.